Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when NVVE files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Delisting (new) — Company received formal Nasdaq delisting notice for failure to file required quarterly report, compounding existing minimum bid price deficiency.
Nuvve receives Nasdaq delisting notice for failing to file Q1 2026 earnings report
Filed May 26, 2026 · Period ending May 22, 2026 · ~1 min read
Key Changes
-
high
Nuvve failed to file its Q1 2026 quarterly report by the deadline, violating Nasdaq's periodic reporting requirements and triggering a formal delisting notice on May 22, 2026.
Item 3.01 verify on EDGAR → -
high
The company now faces two separate Nasdaq deficiencies: the new filing violation plus an existing minimum bid price violation (stock below $1.00 for 30 consecutive days).
Item 3.01 verify on EDGAR → -
high
Nuvve has until May 29, 2026 to request a hearing stay from Nasdaq's panel. If granted, the stay would temporarily prevent suspension for 15 days while the company works to regain compliance.
Item 3.01 verify on EDGAR → -
medium
The company stated it intends to request the stay and work toward regaining compliance, but provided no timeline for filing the overdue quarterly report.
Item 7.01 verify on EDGAR →
Summary
Nuvve disclosed it received a Nasdaq delisting notice on May 22, 2026 for failing to file its first quarter 2026 earnings report on time. This filing violation comes on top of an existing deficiency—the company's stock has traded below $1.00 per share for 30 consecutive days, and Nuvve was already in a hearing process with Nasdaq over that issue.
The combination of two separate listing violations significantly increases delisting risk. For retail investors, this raises immediate concerns about the company's operational and financial health. Missing a quarterly filing deadline often signals internal accounting problems, cash flow stress, or management distraction.
The company has a tight deadline—May 29, 2026—to request a hearing stay, which would buy 15 days of breathing room. However, Nuvve provided no explanation for the filing delay or timeline for when the overdue Q1 report will be released. Watch for whether Nuvve files the missing Q1 report in the coming days and whether it requests the hearing stay by the May 29 deadline. If the company fails on either front, trading suspension could follow quickly.
Section-by-Section Diff
Event · Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule
Nuvve received Nasdaq delisting notice for failing to file Q1 2026 Form 10-Q, adding to prior $1.00 minimum bid price deficiency.
Added in current filing · verify on EDGAR →
On May 22, 2026, Nuvve Holding Corp. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, since the Company had not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Report”), it no longer complies with the Nasdaq's Listing Rule 5250(c) (1) (the “Rule”) relating to the Company's obligation to file periodic financial reports for continued listing.
Nuvve failed to file its Q1 2026 Form 10-Q by the required deadline, violating Nasdaq's periodic reporting rule. This is an additional delisting basis beyond the company's existing minimum bid price deficiency. The company has not filed a required quarterly financial report, which raises questions about its financial condition and operational status.
Added in current filing · verify on EDGAR →
The Notice further stated that since the Company is already before the Panel because the closing price for the Company’s common stock had fallen below $1.00 per share for 30 consecutive trading days under Nasdaq Listing Rule 5550(a) (2), the Company will have seven days, or until May 29, 2026, to request a stay of the suspension
The company is facing two separate Nasdaq listing deficiencies simultaneously: failure to file the Q1 2026 10-Q and a minimum bid price violation (stock below $1.00 for 30 consecutive days). The company was already in a hearing process for the bid price issue when this new filing deficiency arose, compounding its delisting risk.
Event · Item 7.01 — Regulation FD Disclosure
Nuvve received a Nasdaq notice regarding listing compliance; company intends to regain compliance and maintain listing.
Added in current filing · verify on EDGAR →
On May 22, 2026, the Company issued a press release announcing the receipt of the Notice from Nasdaq.
Nuvve disclosed receiving a notice from Nasdaq, which typically relates to non-compliance with listing requirements. The company issued a press release about this notice. The 8-K references the company's intent to regain compliance with 'the Rule' and mentions potential Nasdaq hearing and appeal processes, suggesting the notice involves a listing deficiency that could lead to delisting if not remedied.
Added in current filing · verify on EDGAR →
statements regarding the Company’s intent or ability to regain compliance with the Rule, the outcome of any Nasdaq hearing and appeal process and the Company’s intent or ability to maintain the listing of the Company’s common stock on Nasdaq
The company disclosed forward-looking statements about its intent to regain compliance with Nasdaq rules and maintain its stock listing. The reference to hearing and appeal processes indicates the company may need to take formal steps to address the deficiency and avoid delisting.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · May 28, 2026 · How we verify